Ustekinumab for Intestinal Behçet's Syndrome With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Status
- RECRUITING
- Phase
- PHASE3
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Status
- RECRUITING
- Phase
- PHASE2
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Status
- RECRUITING
- Phase
- N/A
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1